Stock Spotlight: Monash IVF Group Limited (ASX:MVF)
This week's Stock Spotlight is ASX-listed Monash IVF Group Limited.
About Monash IVF Group Limited.
Neurotech International Limited, a clinical-stage biopharmaceutical development company, engages in the research, design, development, and manufacture of medical devices and solutions in Australia. The company is focused on development and commercialisation of NTI164 for multiple paediatric neurological disorders; and Mente, a clinically proven home therapy aimed at enhancing engagement and relaxation in autistic children exhibiting elevated delta band brain activity. It also engages in executing medical research projects; and developing technological devices. The company conducts clinical studies to assess the neuro-protective, anti-inflammatory, and neuro-modulatory activities of its proprietary NTI/Dolce cannabis strains.

Source: Yahoo Finance
Key Stats
Key Stats
Source: Yahoo Finance, ASX. Data as of 11/09/24.
Price Performance
Growth Potential
- Trading below our valuation.
- MVF continues to pick up market share and we don’t see MVF’s core business as discretionary spending.
- High barriers to entry with unique expertise and assets. 40-year heritage of leadership in science and innovation in ARS and women’s imaging, coupled with the depth of experience from the doctors and clinical team which will continue to underpin MVF’s future growth and maintain treatment success rates.
- Aging Australian population and increased age of mothers (especially with the trend of more females choosing career over family until their early thirties) will provide favourable demographic tailwinds.
- Potential earnings diversification and growth via international expansion and increased presence in diagnostics.
- Demonstrated capacity to perform well in terms of cost out and earnings growth despite tough conditions (i.e., lower cycle volumes).
- Potential growth from genetic carrier screening.
Key Risks
- Regulatory risk as changes in government funding may increase patient’s out-of-pocket expenses and thereby volume demand.
- Fluctuations in the availability and size of Medicare rebates may negatively influence the number of IVF cycles administered and overall industry revenue
- The Australian market does not rebound following this period of downturn. Population of males and females with fertility problems decline.
- Loss of key specialists.
- Loss of market share especially to low-cost providers, with one already appearing in Victoria.
- Weakening economic activity resulting in increased unemployment leading to less disposable income to be spent in IVF treatment.
- Execution of international forays into Malaysia goes poorly.
Subscribe to our newsletter
Disclaimer: This article does not constitute financial advice nor a recommendation to invest in the securities listed. The information presented is intended to be of a factual nature only. Past performance is not a reliable indicator of future performance. As always, do your own research and consider seeking financial, legal and taxation advice before investing.
When navigating during uncertain or volatile market conditions, investment portfolios should prioritise caution and flexibility. Holding a healthy cash position is essential as the saying goes ‘cash is king’. Certainly, during frequently shifting market sentiment, facilitating readiness to act when genuine opportunities arise is crucial. For new investments, confirmation of trend reversals or stability before entering positions is a strategy to avoid catching falling knives. For new investments, waiting for confirmation of trend reversals or market stability before entering positions is a prudent strategy to avoid catching falling knives. Implementing a dollar-cost averaging (DCA) approach enables positions to be built gradually, helping to mitigate the effects of market volatility and emotional decision-making. A balanced investment strategy assists in managing risk while positioning a portfolio to capitalise on potential rebounds.
Get the latest BHP Group Ltd (ASX:BHP) stock updates, technical analysis, market forecasts & investment insights. See if BHP is the right stock for you today.
Gold is once again making headlines in 2025 as its value has risen to unprecedented levels since the start of the year. It recently surpassed $3000 USD per ounce as investors flock to its time tested safe-haven appeal. This isn’t just another bull run, a powerful combination of geopolitical shifts, inflation fears, and changing market dynamics is fuelling what could be gold's most significant rally in decades.
Get the latest Commowealth Bank Of Australia (ASX:CBA) stock updates, technical analysis, forecasts & investment insights. See if CBA is the right stock for you.
When US stocks plummeted by almost 4%, with NVDA down by 7% and Apple down by 4%, Bitcoin dropped by almost 15%. Why did this happen? 
Get the latest CSL Limited (ASX: CSL) stock updates, technical analysis, expert forecasts & investment insights. See if CSL is the right stock for you!
The global financial landscape has been rocked by escalating trade tensions, with US policies under President Donald Trump causing significant market fluctuations. Investors worldwide are grappling with uncertainty as tariff threats, economic instability, and geopolitical risks weigh heavily on equity markets. This article explores the effects of these factors on both the Australian Securities Exchange (ASX) and US equity markets.
This week's Stock Spotlight is NYSE-listed Wells Fargo & Company. About Wells Fargo & Company. Wells Fargo & Company, a financial services company, provides diversified banking, investment, mortgage, and consumer and commercial finance products and services in the United States and internationally. The company operates through four segments: Consumer Banking and Lending; Commercial Banking; Corporate and Investment Banking; and Wealth and Investment Management. The Consumer Banking and Lending segment offers diversified financial products and services for consumers and small businesses. Its financial products and services include checking and savings accounts, and credit and debit cards, as well as home, auto, personal, and small business lending services. The Commercial Banking segment provides financial solutions to private, family owned, and certain public companies. Its products and services include banking and credit products across various industry sectors and municipalities, secured lending and lease products, and treasury management services. The Corporate and Investment Banking segment offers a suite of capital markets, banking, and financial products and services, such as corporate banking, investment banking, treasury management, commercial real estate lending and servicing, equity, and fixed income solutions, as well as sales, trading, and research capabilities services to corporate, commercial real estate, government, and institutional clients. The Wealth and Investment Management segment provides personalized wealth management, brokerage, financial planning, lending, private banking, and trust and fiduciary products and services to affluent, high-net worth, and ultra-high-net worth clients. It also operates through financial advisors in brokerage and wealth offices, consumer bank branches, independent offices, and digitally through WellsTrade and Intuitive Investor. The company was founded in 1852 and is headquartered in San Francisco, California. Source: Yahoo Finance Key Stats
Self-Managed Super Funds (SMSFs) are a powerful way for Australians to take control of their retirement savings. But to achieve long-term growth and financial security, SMSF investors need the right strategy—one that includes both Australian and US shares. At Sharewise, we specialise in helping SMSF investors navigate both ASX and US markets with expert research, low-cost execution, and tax-efficient investment strategies.
This week's Stock Spotlight is NYSE-listed Taiwan Semiconductor Manufacturing Company Limited. About Taiwan Semiconductor Manufacturing Company Limited. Taiwan Semiconductor Manufacturing Company Limited, together with its subsidiaries, manufactures, packages, tests, and sells integrated circuits and other semiconductor devices in Taiwan, China, Europe, the Middle East, Africa, Japan, the United States, and internationally. It provides a range of wafer fabrication processes, including processes to manufacture complementary metal- oxide-semiconductor (CMOS) logic, mixed-signal, radio frequency, embedded memory, bipolar CMOS mixed-signal, and others. The company also offers customer and engineering support services; manufactures masks; and invests in technology start-up companies; researches, designs, develops, manufactures, packages, tests, and sells color filters; and provides investment services. Its products are used in high performance computing, smartphones, Internet of things, automotive, and digital consumer electronics. The company was incorporated in 1987 and is headquartered in Hsinchu City, Taiwan.  Source: Yahoo Finance Key Stats
